Response to DEFRA consultation
Summary by AI BETAClose X
28 January 2026
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Response to DEFRA consultation on the Veterinary Surgeons Act 1966
CVS welcomes the announcement by the Department for Environment, Food and Rural Affairs (DEFRA) that they will be commencing a consultation on proposed reforms to the Veterinary Surgeons Act 1966 (VSA).
Reform of the VSA was a remedy recommended by the Competition and Markets Authority (CMA), along with price transparency, in its October 2025 provisional decision of its market investigation into veterinary services for household pets in the UK and the Government had previously announced its intention to consult on this.
CVS has been calling for reform to the VSA for some time and has engaged with both DEFRA and the CMA during the market investigation to share its views on these expected reforms. CVS believes reform will help strengthen consumer confidence in the profession, ensure enhanced regulation including practice level accountability for maintaining appropriate standards such as mandatory compliance with the voluntary Practice Standards Scheme (PSS) which CVS practices embrace. CVS also believes that expanding the scope and role of Registered Veterinary Nurses to undertake a wider range of procedures is long overdue.
CVS understands the consultation will last for eight weeks and looks forward to continuing its dialogue with DEFRA, and to sharing its thoughts during the consultation.
The Group continues to expect to deliver FY2026 results in line with the Board's expectations.
Paul Higgs, Chief Veterinary Officer commented: "The Veterinary Profession has been calling for reform of the outdated Veterinary Surgeons Act for over a decade, something CVS continues to be supportive of. We are pleased to see the Government take the opportunity of the CMA investigation to accelerate this process."
Contacts
CVS Group plc via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Camarco (Financial PR) cvsg@camarco.co.uk
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is a leading provider of veterinary services with operations in the UK and Australia. CVSG is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical and support teams at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVSG operates Laboratories (providing diagnostic services to CVSG and third-parties) and an Online Retail Business.
The Group employs c.8,900 personnel, including c.2,500 veterinary surgeons and c.3,300 nurses and patient care assistants.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund